文献速递瓣膜外科

替代入路经导管主动脉瓣置换术的演变

Evolution of Alternative-access Transcatheter Aortic Valve Replacement.
PubMed 文献 · Ann Thorac Surg · 2021-02-27

该研究回顾了克利夫兰诊所2006年至2019年间2446例TAVR患者,其中414例(17%)采用替代入路。随时间推移,首选替代入路从经心尖和经主动脉转向经腋。经腋入路较经胸腔入路输血更少、通气时间更短、住院更短,且与经股动脉入路结果相当。

要点

  • 替代入路TAVR占17%,经腋入路已成为首选替代策略。
  • 经腋入路较经心尖/经主动脉入路输血更少、通气更短、住院更短。
  • 经腋与经股动脉匹配比较生存和主要并发症相似。

核心结论

  • 经腋入路已成为该中心首选的替代入路TAVR策略,其手术结果优于经胸腔入路,并与经股动脉入路相当。

研究设计与样本

  • 单中心回顾性研究,2006年1月至2019年1月共2446例TAVR患者,其中414例(17%)采用替代入路。

主要发现

  • 非风险调整5年生存率替代入路组较低(45% vs 59%)。

临床怎么用

  • 对于需要替代入路的TAVR患者,经腋入路可作为首选替代策略。
  • 经腋入路在匹配比较中与经股动脉入路生存和主要并发症相似。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Transfemoral access is the most common approach for transcatheter aortic valve replacement (TAVR). However, a subset of patients require alternative access. This study describes the evolution and outcomes of alternative-access TAVR at Cleveland Clinic. METHODS: From January 2006 to January 2019, 2446 patients underwent TAVR, 414 (17%) through alternative access (247 transapical, 95 transaortic, 56 transaxillary, 2 transcarotid, 10 transiliac, 4 transcaval). Patients undergoing alternative-access TAVR had high preoperative risk. Propensity-matched comparisons were targeted at comparing transfemoral versus transaxillary approaches since 2012. RESULTS: Over time, the favored alternative-access approach shifted from transapical and transaortic to transaxillary. Pacemaker requirement was similar for alternative-access and transfemoral approaches. Compared with transfemoral access, major vascular injuries were higher in the alternative-access group (12 [2.9%] vs 27 [1.3%], P = .02), but minor vascular injuries were lower (13 [3.1%] vs 198 [9.8%], P < .0001). Non-risk-adjusted 5-year survival was lower in the alternative-access group (45% vs 59%). Compared with intrathoracic approaches (transapical and transaortic), transaxillary access was associated with fewer blood transfusions (12 [21%] vs 176 [51%], P < .0001), less prolonged ventilation (1 [1.8%] vs 38 [11%], P = .03), and shorter length of stay (median, 5 vs 7.5 days, P < .0001). Survival and major morbidity were similar in matched comparisons of the transfemoral and transaxillary approaches. No brachial plexus injuries occurred with transaxillary access. CONCLUSIONS: The transaxillary approach has emerged as our preferred alternative-access strategy for TAVR. It is associated with superior operative outcomes compared with transthoracic approaches, and results are comparable with those of the transfemoral approach.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Kindzelski B, Mick SL, Krishnaswamy A, et al. Evolution of Alternative-access Transcatheter Aortic Valve Replacement. Ann Thorac Surg. 2021. PMID: 33647251. doi:10.1016/j.athoracsur.2021.02.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。